A Practical Atlas Of Breast Biopsy Needles in Eight Core Areas

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

As the "golden sampler" for breast disease diagnosis, the clinical value of breast biopsy needles has long transcended their single function of tissue acquisition, permeating key aspects of the entire breast diagnosis and treatment process. This article, based on evidence-based medicine, systematically outlines their differentiated application strategies in eight core scenarios.

I. Qualitative Diagnosis of Suspicious Masses

When palpation reveals a mass with indistinct borders and a firm texture, the breast biopsy needle is the preferred tool for differentiating between benign and malignant masses. For solid masses with a diameter >2cm, 14G core needle biopsy (CNB) can obtain sufficient tissue strips, achieving a diagnostic accuracy of 98.7%, significantly higher than the 85.2% of fine-needle aspiration cytology (FNAC). During the procedure, attention should be paid to the "three-zone sampling method": taking 1-2 tissue strips from the edge, center, and subcapsular region of the mass to avoid false negatives caused by necrotic areas. For predominantly cystic cystic-solid masses, it is recommended to first aspirate the cystic fluid with a 22G fine needle, then switch to an 18G needle for biopsy of the solid component. This step-by-step strategy can improve the diagnostic accuracy by 12%.

II. Precise Capture of Microcalcifications

Clustered microcalcifications (≥5 calcifications/cm²) detected on mammograms are an important sign of ductal carcinoma in situ. The application of breast biopsy needles in this scenario is extremely challenging: a 20G×7cm specialized positioning needle must be used, and "concentric sampling" must be performed under stereotactic guidance-puncturing three times at a 45° angle within a 1cm radius around the calcification. To improve the capture rate, some devices are equipped with vacuum-assisted devices, which increase the probability of microcalcification particles entering the needle groove by 40% through negative pressure adsorption. It is important to note that an X-ray of the specimen must be taken immediately after the procedure to confirm the presence of calcified tissue; otherwise, a second biopsy is required.

III. Differential Diagnosis of Complex Cysts

For BI-RADS 3 complex cysts, the breast biopsy needle plays a crucial role in ruling out malignancy. Key points of the procedure include: ① Using a 22G thin-walled needle to minimize cyst wall damage; ② Maintaining stable negative pressure during aspiration to prevent air contamination from affecting ultrasound observation; ③ Testing the cyst fluid for CEA and CA15-3; elevated values ​​suggest possible intracystic papilloma; ④ Using a "scraping method" to gently scrape away epithelial cells from cyst wall nodules using the bevel of the needle. Studies show that this comprehensive strategy can reduce the misdiagnosis rate of complex cysts to below 0.3%.

IV. Localization Biopsy of Inaccessible Lesions

When the lesion can only be detected by imaging (not palpable), the breast biopsy needle must be used in conjunction with a localization guidewire. The procedure is as follows: Preoperatively, under image guidance, a barbed guidewire is placed next to the lesion, followed by the insertion of a 14G biopsy needle along the guidewire channel to perform "guidewire-guided continuous sampling." The challenge of this technique lies in controlling the angle between the needle and the guidewire (ideally <15°), as an excessively large angle can lead to sampling deviation. The newly developed coaxial positioning needle integrates the guidewire and biopsy channel, reducing operation time by 40% and improving positioning accuracy to 99.2%.

V. Etiology of Nipple Discharge

For unilateral, single-port bloody or serous nipple discharge, the breast biopsy needle can be guided into the responsible duct using a ductoscope. A 20G ultrafine soft needle is used to perform brushing or cutting biopsies on dilated segments or space-occupying lesions under direct ductoscopy. The key to this technique is maintaining duct filling-continuous injection of physiological saline to maintain luminal tension can improve lesion detection rate by 35%. Pathological results show that this method has a diagnostic sensitivity of 92.6% for intraductal papilloma, significantly higher than the 68.3% of exfoliative cytology.

VI. Etiological Diagnosis of Inflammatory Lesions

In the diagnosis and treatment of inflammatory diseases such as granulomatous mastitis and plasma cell mastitis, breast biopsy needles are used not only to obtain tissue specimens but also for bacterial culture and drug sensitivity testing. A 16G side-hole needle is recommended for ultrasound-guided multi-point sampling of the abscess wall, avoiding the low pathogen detection rate (only 38%) caused by simply aspirating pus. Simultaneously, the granulation tissue obtained by the needle can be used for Mycobacterium tuberculosis PCR detection, shortening the diagnostic time for tuberculous mastitis from an average of 21 days to 72 hours.

VII. Dynamic Monitoring of Treatment Response

During neoadjuvant chemotherapy, breast biopsy needles play a crucial role in efficacy assessment. It is recommended to perform a repeat biopsy at the end of the second chemotherapy cycle, using an 18G needle to obtain a second sample from the same lesion's original sampling area. The probability of pathological complete remission (pCR) can be predicted by comparing changes in tumor cell density (Miller-Payne grading). Studies have confirmed that this dynamic monitoring can achieve a pCR prediction accuracy of 89%, guiding timely adjustments to clinical treatment plans. During the procedure, care must be taken to avoid areas of tissue fibrosis caused by chemotherapy to prevent obtaining invalid samples.

VIII. Sample Collection for Translational Medicine Research

In breast cancer molecular subtyping research, fresh tissue obtained from breast biopsy needles is a crucial sample source for gene testing. Specialized RNA-protected needles (with built-in RNAlater preservation solution) must be used. The needle lumen must be sealed immediately after puncture, and the needles must be transported to the laboratory at 4°C. The inner surface of these needles is silanized to reduce RNase adsorption contamination, maintaining mRNA integrity above 90%. This standardized sampling method achieves a high degree of consistency between ER, PR, HER2, and postoperative paraffin section results (Kappa value = 0.87).

From routine diagnosis to cutting-edge research, the application scenarios of breast biopsy needles are constantly expanding, and their technological iterations consistently revolve around the core goals of "precise acquisition, minimal damage, and maximum information content." With advancements in molecular pathology, future biopsy needles may integrate in-situ detection capabilities, realizing the ultimate vision of "diagnosis upon puncture."